Cervical Cancer

Personalised treatments designed to fight cervical cancer while minimising side effects.

What is Cervical Cancer?

Cervical cancer arises from the cervix, the lower part of the uterus that connects to the vagina. It is a significant health concern in Southeast Asia. While rates have fallen in countries with widespread vaccination and screening, cervical cancer remains among the top cancers affecting women in Philippines and the region.

Most cases are caused by persistent infection with the human papillomavirus (HPV). The two most common types are squamous cell carcinoma and adenocarcinoma, which are treated in similar ways. Rare types, such as small-cell neuroendocrine carcinoma, are less common.

How common is cervical cancer in the Philippines?

Cervical cancer remains one of the most common cancers among women in the Philippines. 

According to the IARC Global Cancer Observatory (GLOBOCAN 2022): 

  • An estimated 8,549 women in the Philippines were newly diagnosed with cervical cancer in 2022.  
  • An estimated 4,380 women died from cervical cancer in 2022.  
  • Cervical cancer is the third most common cancer among women in the Philippines, accounting for 8.1% of new cancer cases in women.  
  • The estimated age-standardized incidence rate is 15.5 per 100,000 women, and the age-standardized mortality rate is 8.0 per 100,000 women.  

These figures highlight the importance of regular screening and HPV vaccination to help reduce the burden of cervical cancer. The WHO recommends HPV testing as a primary screening approach and HPV vaccination for girls aged 9–14 years as a key prevention strategy. 

What Are the Signs and Symptoms of Cervical Cancer?

In the early stages, cervical cancer often does not cause symptoms. As the disease progresses, women may notice:

If these symptoms are present, especially if persistent, it is important to see a healthcare professional promptly.

Screening for Cervical Cancer

Screening helps detect pre-cancerous changes or early-stage cancer before symptoms appear, when treatment is most effective.

InPhilippines and many parts of the region, recommended screening options include:

Pap smear (Pap test)
Starting from age 25 for women who are or have been sexually active. The test looks for abnormal cells on the cervix that may develop into cancer.
Starting from age 30, this test detects high-risk HPV strains that cause most cervical cancers. It may be done alone or combined with a Pap test.
A cost-effective alternative sometimes used in community settings, where vinegar is applied to the cervix and abnormal areas turn white.

Regular screening is important even for women who have received the HPV vaccine, as the vaccine does not cover all cancer-causing HPV strains.

How is Cervical Cancer Diagnosed?

If cervical cancer is suspected, doctors may recommend:

What Are the Causes and Risk Factors of Cervical Cancer?

Almost all cases of cervical cancer (about 99%) are linked to high-risk HPV infection, transmitted through sexual contact.

Other risk factors include:

  • Having multiple sexual partners or early onset of sexual activity
  • Smoking
  • A weakened immune system (e.g. HIV infection, long-term immunosuppressive therapy)
  • Long-term use of oral contraceptive pills
  • Multiple full-term pregnancies

What Are the Types of Cervical Cancer?

The main types of cervical cancer are:

What Are the Stages of Cervical Cancer?

Staging helps guide treatment. Based on the FIGO system, the stages are:

Stage I

Cancer is confined to the cervix

Cancer has spread to nearby areas such as the uterus, upper vagina, or tissues around the cervix

Cancer extends to the lower vagina, pelvic wall, or causes kidney blockage; may involve lymph nodes

Cancer has spread to the bladder, rectum, or distant organs such as lungs, liver, or bones

What Are Cervical Cancer Treatments?​

Treatment depends on the stage, overall health, and fertility wishes of the patient.

Surgery

Hysterectomy or fertility-sparing surgery for selected patients

Radiotherapy

If surgery is not suitable

Concurrent chemo-radiation

Combines radiation with chemotherapy (commonly cisplatin)

Brachytherapy and external beam radiation

Targeted Therapy
(e.g. Bevacizumab)

Immunotherapy

Newer option in selected patients, often outpatient

How common is cervical cancer in the Philippines?

Cervical cancer remains one of the most common cancers among women in the Philippines. 

According to the IARC Global Cancer Observatory (GLOBOCAN 2022): 

  • An estimated 8,549 women in the Philippines were newly diagnosed with cervical cancer in 2022.  
  • An estimated 4,380 women died from cervical cancer in 2022.  
  • Cervical cancer is the third most common cancer among women in the Philippines, accounting for 8.1% of new cancer cases in women.  
  • The estimated age-standardized incidence rate is 15.5 per 100,000 women, and the age-standardized mortality rate is 8.0 per 100,000 women.  

 These figures highlight the importance of regular screening and HPV vaccination to help reduce the burden of cervical cancer. The WHO recommends HPV testing as a primary screening approach and HPV vaccination for girls aged 9–14 years as a key prevention strategy. 

Meet Our Doctors

At OncoCare Philippines, our cancer specialists are experienced in treating cervical cancer and other gynaecological cancers. Our multidisciplinary team offers personalised treatment plans and access to the latest therapies, combining medical expertise with compassionate care to support women at every stage of their journey.

Dr. Angelo Miguel M. Realina
Palliative Care Specialist | Interventional Pain Management Specialist
Dr. Arthur Jason S. Go
Medical Oncologist
Dr. Beverly Ann P. Pineda
Medical Oncologist 
Dr. Carlo Ruperto P. Aguilar
Radiation Oncologist
Dr. Carlos Joseph T. Panaligan Jr.
Consultant Anesthesiologist
Dr. Claudine Yvette S. Gulapa
Anesthesiologist
Dr. Gonzalo C. Banuelos, Jr.
Radiation Oncologist
Dr. Jason King D. Talao
Medical Oncologist 
Dr. Jerickson Abbie S. Flores
Radiation Oncologist
Dr. Joel R. Tayo
Medical Oncologist
Dr. Jose Enrique Y. Montoya
Medical Oncologist
Dr. Karl Jeremy B. Lo
Radiation Oncologist
Dra. Kristine Anne B. Monte
Internal Medicine Specialist
Dr. Marwin M. Manalo
Medical Oncologist
Dr. Misael C. Cruz
Radiation Oncologist
Dr. Noel S. Chua
Medical Oncologist
Dr. Paulo S. Tioleco
Medical Oncologist
Dra. Rosalina P. Tongol
Internal Medicine

Colorectal (Colon) Cancer

Personalised treatments designed to fight cancer while minimising side effects.

What is Colorectal (Colon) Cancer?

Colorectal cancer (CRC) develops in the colon or rectum, often beginning as small growths called polyps that can turn cancerous over time if not removed. Because the colon and rectum are part of the digestive tract, colorectal cancer is sometimes referred to as “colon cancer.”

In Philippines, colorectal cancer is the most common cancer among men and the second most common among women, according to the Philippines National Cancer Registry (MNCRR 2017–2021). Unfortunately, a significant proportion of patients are still diagnosed at Stage 3 or 4, when the disease is harder to treat effectively.

How common is colorectal cancer in the Philippines?

Colorectal cancer (cancer of the colon and rectum) is a major cancer burden in the Philippines. 

According to the IARC Global Cancer Observatory (GLOBOCAN 2022): 

  • Colorectal cancer is the 3rd most common cancer overall in the Philippines, with an estimated 20,736 new cases in 2022—about 11.0% of all new cancer cases. 
  • It is also a leading cause of cancer death, with an estimated 10,692 deaths in 2022 (ranked 4th among all cancers). 
  • The estimated age-standardized incidence rate (ASR) for colorectal cancer (both sexes) is 20.8 per 100,000, and the age-standardized mortality rate is 10.8 per 100,000.  

Because colorectal cancer can often be detected earlier through screening, improving access to appropriate screening tests—such as stool-based tests (e.g., FIT) followed by confirmatory procedures when needed—can help improve outcomes. 

What Are the Signs and Symptoms of Colorectal Cancer?

In its early stages, colorectal cancer may cause no noticeable symptoms. As the cancer grows, symptoms may include:

These symptoms may be caused by other conditions, but if they persist, medical evaluation is important.

Screening for Colorectal Cancer

Early detection through screening saves lives. In Philippines, guidelines recommend:

  • Faecal Immunochemical Test (FIT) – A stool test to detect hidden blood. Recommended yearly or biennially for adults aged 50 and above, or earlier if high risk
  • Colonoscopy – The gold standard for detecting and removing polyps before they turn cancerous. Typically advised every 10 years for average-risk individuals, sooner if family history or other risk factors are present
  • Flexible Sigmoidoscopy – May be used as an alternative in some cases

Individuals with a family history of colorectal cancer, inflammatory bowel disease, or genetic syndromes such as Lynch syndrome should begin screening earlier and repeat it more frequently.

How is Colorectal Cancer Diagnosed?

Diagnosis usually involves:

What Are the Causes and Risk Factors of Colorectal Cancer?

While the exact cause is not always known, several risk factors increase the likelihood of developing colorectal cancer:

  • Age 50 and above
  • Family history of colorectal cancer or polyps
  • Hereditary syndromes (e.g., Lynch syndrome)
  • Diet low in fibre and high in red or processed meats
  • Obesity and lack of physical activity
  • Smoking and heavy alcohol intake
  • Inflammatory bowel disease (ulcerative colitis, Crohn’s disease)

What Are the Types of Colorectal Cancer?

The most common types include:

What Are the Stages of Colorectal Cancer?

Staging describes how advanced the cancer is:

Stage 0 (in situ)

Cancer cells limited to the innermost lining

Cancer confined to the colon/rectum wall or slightly beyond, no lymph nodes

Cancer has spread to nearby lymph nodes

Cancer has spread (metastasised) to distant organs like the liver or lungs

The stage at diagnosis is critical in determining treatment and prognosis.

What Are Colorectal Cancer Treatments?

Treatment depends on the stage, overall health, and fertility wishes of the patient.

Polypectomy

(Removal of polyps) during colonoscopy

Surgery

(Laparoscopic or robotic) to remove the tumour and nearby lymph nodes

Surgery + adjuvant chemotherapy

(To reduce recurrence)

Chemoradiation

Often used for rectal cancers before surgery

Systemic chemotherapy

(E.g., FOLFOX, FOLFIRI)

Targeted Therapy

(Anti-EGFR or anti-VEGF agents, depending on tumour genetics)

Immunotherapy

PD-1 inhibitors) for MSI-H/dMMR cancers

Metastasis-directed treatment

(Surgery, ablation) in selected patients

Palliative treatments

To control symptoms and maintain quality of life

How common is colorectal cancer in the Philippines?

Colorectal cancer (cancer of the colon and rectum) is a major cancer burden in the Philippines. 

According to the IARC Global Cancer Observatory (GLOBOCAN 2022): 

  • Colorectal cancer is the 3rd most common cancer overall in the Philippines, with an estimated 20,736 new cases in 2022—about 11.0% of all new cancer cases.
  • It is also a leading cause of cancer death, with an estimated 10,692 deaths in 2022 (ranked 4th among all cancers).
  • The estimated age-standardized incidence rate (ASR) for colorectal cancer (both sexes) is 20.8 per 100,000, and the age-standardized mortality rate is 10.8 per 100,000.  

Because colorectal cancer can often be detected earlier through screening, improving access to appropriate screening tests—such as stool-based tests (e.g., FIT) followed by confirmatory procedures when needed—can help improve outcomes. 

Meet Our Doctors

In Philippines, our team includes colorectal oncologists, surgeons, radiation specialists, pathologists, nurses and allied health professionals. They work together to deliver personalised treatment and care for every patient.

Dr. Angelo Miguel M. Realina
Palliative Care Specialist | Interventional Pain Management Specialist
Dr. Arthur Jason S. Go
Medical Oncologist
Dr. Beverly Ann P. Pineda
Medical Oncologist 
Dr. Carlo Ruperto P. Aguilar
Radiation Oncologist
Dr. Carlos Joseph T. Panaligan Jr.
Consultant Anesthesiologist
Dr. Claudine Yvette S. Gulapa
Anesthesiologist
Dr. Gonzalo C. Banuelos, Jr.
Radiation Oncologist
Dr. Jason King D. Talao
Medical Oncologist 
Dr. Jerickson Abbie S. Flores
Radiation Oncologist
Dr. Joel R. Tayo
Medical Oncologist
Dr. Jose Enrique Y. Montoya
Medical Oncologist
Dr. Karl Jeremy B. Lo
Radiation Oncologist
Dra. Kristine Anne B. Monte
Internal Medicine Specialist
Dr. Marwin M. Manalo
Medical Oncologist
Dr. Misael C. Cruz
Radiation Oncologist
Dr. Noel S. Chua
Medical Oncologist
Dr. Paulo S. Tioleco
Medical Oncologist
Dra. Rosalina P. Tongol
Internal Medicine